Diabetic Foot Ulcer and Amputation Statistics (2026): The Numbers in One Table
Every major published figure on diabetic foot ulcers and amputation in three sourced tables, from how common ulcers are to healing, recurrence and death, and the surgery, team care and offloading results that lower them.
By Dr. Efe Ozturk
· 12 min read
Medically reviewed by Dr. Efe Ozturk · Last reviewed

A diabetic foot ulcer is an open sore on the foot of a person with diabetes, usually on the sole or toes, that is slow to heal. Here are the published numbers, with sources and years. Where sources disagree, each gets its own row.
Key figures
- In a 1998 randomized trial of 42 people with uninfected nerve-related foot ulcers, surgery healed 95.5% of ulcers in a mean of 46.73 days, against 79.2% in 128.9 days with non-surgical care.[1]
- In a 2003 randomized trial of 64 people with nerve-related ulcers under the forefoot, 38% had an ulcer come back about two years after a cast plus Achilles tendon lengthening, against 81% after a cast alone.[2]
- In a 2001 randomized trial of 63 people with ulcers on the sole, 89.5% healed within 12 weeks in a total contact cast, against 65.0% in a removable cast walker and 58.3% in a half-shoe.[6]
- About 18.6 million people worldwide, including 1.6 million in the United States, are affected by a diabetic foot ulcer each year, a 2023 JAMA review estimated.[4]
- In the United States in 2021, there were 6.2 lower-limb amputations for every 1,000 adults with diagnosed diabetes, according to Healthy People 2030 data.[7]
- In a 2020 pooled analysis, 30.5% of people died within five years of a diabetic foot ulcer, close to the 31.0% five-year mortality for all reported cancers.[8]
Diabetic foot ulcer statistics: how common are they?
| Statistic | Figure | Population or setting | Year | Source |
|---|---|---|---|---|
| People with diabetes | 40.1 million, diagnosed or undiagnosed | United States | 2023 data | CDC[9] |
| People with a foot ulcer each year | About 18.6 million | Worldwide | 2023 review | Armstrong, JAMA[4] |
| People with a foot ulcer each year | About 1.6 million | United States | 2023 review | Armstrong, JAMA[4] |
| Lifetime risk of a foot ulcer | 19% to 34% | People with diabetes | 2023 review | McDermott, Diabetes Care[5] |
| New ulcers each year | 2.2% a year | Community patients, North-west England | 2002 cohort | Abbott, Diabet Med[10] |
| Prevalence | 6.3% worldwide; 13.0% in the USA | People with diabetes, pooled studies | 2017 meta-analysis | Zhang, Ann Med[11] |
| Ulcers that become infected | 50% to 60% | Diabetic foot ulcers | 2023 review | Armstrong, JAMA[4] |
| Ulcers with peripheral artery disease | About 50% | People with diabetes and a foot ulcer | 2023 guideline | IWGDF, ESVS and SVS[12] |
| Amputations that follow an ulcer | 80% | People with diabetes | 2023 review | Armstrong, JAMA[4] |
| Lower-limb amputations | 6.2 per 1,000 adults with diagnosed diabetes (age-adjusted) | US adults 18 and older | 2021 data | Healthy People 2030[7] |
Peripheral artery disease means narrowed leg arteries that cut blood flow to the foot. The US rate showed little or no detectable change from 2019 to 2021, against a 2030 target of 5.5 per 1,000.[7]
Diabetic foot ulcer mortality rate, healing and amputation
| Statistic | Figure | Population or setting | Year | Source |
|---|---|---|---|---|
| Healed by 12 weeks | About 30% to 40% | Across studies | 2023 review | Armstrong, JAMA[4] |
| Healed; amputation | Healed 26% by 12 weeks, 49% by 32 weeks; amputation 4% and 10% at those weeks | 419 people, Diabetic Foot Consortium | 2026 study | Xu, Wound Repair Regen[13] |
| Healed by 12, 20 and 52 weeks | 59.3%, 70.5% and 86.6% | 410 nerve-related ulcers without artery disease or infection, one unit | 2007 study | Ince, Diabetes Care[14] |
| Outcomes at 12 months | 45.5% healed; 17.4% amputation, same leg; 15.1% died | 299 people with an infected ulcer | 2018 study | Ndosi, Diabet Med[15] |
| Ulcer comes back | 42% at 1 year; 65% at 5 years | Healed ulcers | 2023 review | Armstrong, JAMA[4] |
| Ulcer comes back | 65% at 3 to 5 years | Healed ulcers | 2023 review | McDermott, Diabetes Care[5] |
| Ulcer comes back | 22.1% per person-year (17.8% in North America) | 49 studies | 2019 meta-analysis | Fu, Diabetes Metab Res Rev[16] |
| Moderate to severe infections ending in amputation | About 20% | Infected ulcers | 2023 review | Armstrong, JAMA[4] |
| Lifetime amputation after an ulcer | 20% | People with a foot ulcer | 2023 review | McDermott[5] |
| Major amputation after a partial foot amputation | 23% | 46 studies, 32,496 people with diabetes | 2026 meta-analysis | Greenfield, J Vasc Surg[17] |
| Death rate, with vs without an ulcer | 231 vs 182 per 1,000 person-years | People with diabetes | 2023 review | Armstrong, JAMA[4] |
| Five-year mortality after an ulcer | About 30% | People with a foot ulcer | 2023 review | Armstrong, JAMA[4] |
| Five-year mortality after an ulcer | 30.5% | Pooled studies | 2020 pooled analysis | Armstrong, J Foot Ankle Res[8] |
| Five-year mortality after an ulcer | 50% to 70% | People with a foot ulcer | 2023 review | McDermott[5] |
| Five-year mortality after amputation | Minor (toe or part of the foot) 46.2%; major (above the ankle) 56.6% | Pooled studies | 2020 pooled analysis | Armstrong 2020[8] |
| Mortality, minor amputation | 20% at 1 year; 44.1% at 5 years | 28 studies, 17,325 people with diabetes or artery disease | 2020 meta-analysis | Yammine, J Vasc Surg[18] |
| Mortality, major amputation | 27.3% at 1 year; 63.2% at 5 years | 8,184 people with diabetes | 2021 meta-analysis | Meshkin, J Foot Ankle Surg[19] |
| Mortality, major amputation | 28.9% at 1 year; 63.0% at 5 years | 59,999 people with artery disease or diabetes | 2026 meta-analysis | Leatherby, Eur J Vasc Endovasc Surg[20] |
| Five-year mortality, major amputation | 67.0% with diabetes vs 57.1% without | 2,542 people, Wales | 2025 study | Hayes, Diabetes Res Clin Pract[21] |
| Five-year mortality, major amputation | Over 70% | People with diabetes | 2023 review | Armstrong, JAMA[4] |
| Five-year mortality, cancers | 31.0% all reported cancers; 9.0% breast; 80.0% lung | People with cancer, for comparison | 2020 pooled analysis | Armstrong 2020[8] |
Five-year death rates after an ulcer run from about 30% to 70% across these sources, which pooled different studies. Our Limb Salvage Institute explains what drives them in life expectancy after a diabetic amputation, and what the 4-week check means in diabetic foot ulcer healing time.
What lowers the numbers: limb salvage surgery, team care and offloading
| Statistic | Figure | Population or setting | Year | Source |
|---|---|---|---|---|
| Surgery vs non-surgical care | Healed 95.5% vs 79.2%; 46.73 vs 128.9 days | Randomized trial, 42 people, uninfected ulcers | 1998 trial | Piaggesi, Diabet Med[1] |
| Achilles lengthening plus cast vs cast alone | Ulcer came back: 15% vs 59% at 7 months; 38% vs 81% at about 2 years | Randomized trial, 64 people, forefoot ulcers, tight ankle | 2003 trial | Mueller, J Bone Joint Surg Am[2] |
| Metatarsal head resection vs standard care | Failure to heal, recurrence and infection 4 times higher, amputation 2 times higher, with standard care | 11 studies, 477 people; comparisons in uninfected ulcers | 2021 meta-analysis | Yammine, Adv Wound Care[22] |
| Flexor tenotomy (toe tendon release) | 97% of toe ulcers healed, mean 29.5 days; 6% came back | 6 studies, 264 tenotomies | 2017 systematic review | Bonanno, J Foot Ankle Surg[23] |
| Revascularization (restoring blood flow) | Limb kept at 1 year: 80% endovascular, 85% open surgery; median 60% healed at 1 year | 64 studies, more than 13,000 people with artery disease | 2020 systematic review | Forsythe, Diabetes Metab Res Rev[24] |
| Multidisciplinary team | 31 of 33 studies (94%) reported fewer major amputations | 33 observational studies | 2020 systematic review | Musuuza, J Vasc Surg[3] |
| Team care vs usual care | Major amputation 3.2% vs 4.4% (odds ratio 0.40) | People with a foot ulcer | 2023 review | Armstrong, JAMA[4] |
| Team that includes a podiatrist | Major amputation risk ratio 0.45; any amputation 0.69 | 12 studies | 2020 meta-analysis | Blanchette, J Foot Ankle Res[25] |
| Dedicated teams and care pathways | Major amputation odds ratio 0.52 (48% lower); any amputation 0.71 | 7 studies, type 2 diabetes | 2021 meta-analysis | Meza-Torres, Acta Diabetol[26] |
| Early vs late referral to a foot center | Healed 89.9% vs 41.5%; major amputation 0.6% vs 36.6%; died 4.4% vs 19.5% at 6 months | 200 people, one specialist center | 2021 study | Meloni, Acta Diabetol[27] |
| Time from first symptoms to specialist | Median 15 to 126 days | 32 studies of foot ulcers or severe leg artery disease, high-income countries | 2020 systematic review | Nickinson, J Vasc Surg[28] |
| Total contact cast vs removable walker vs half-shoe | Healed by 12 weeks: 89.5% vs 65.0% vs 58.3% | Randomized trial, 63 people | 2001 trial | Armstrong, Diabetes Care[6] |
| Non-removable vs removable offloading device | Risk ratio 1.24 for ulcers healed | 14 studies, 1,083 people | 2024 meta-analysis | Lazzarini, Diabetes Metab Res Rev[29] |
| Pressure-relieving footwear vs usual care | New ulcer 13.3% vs 25.4% | People at risk of ulcers | 2023 review | Armstrong, JAMA[4] |
For an ulcer under the ball of the foot that hasn’t healed with non-surgical offloading, the international guideline advises considering Achilles tendon lengthening, metatarsal head resection or a metatarsal osteotomy. For an ulcer on the second to fifth toes from a flexible bent toe, it advises a flexor tenotomy. It advises considering imaging and revascularization when an ulcer shows no sign of healing in 4 to 6 weeks.[30] The ADA’s 2026 Standards of Care recommend a team approach facilitated by a podiatrist for foot ulcers and high-risk feet. For deformities or repeat ulcers that footwear alone can’t manage, they advise considering surgical reconstruction by an experienced diabetic foot surgeon.[31]
What the numbers mean for you
A diabetic foot ulcer is serious, and it is treatable. The surgical studies show what happens when the cause is removed: bone pressing on the ulcer, a tight calf or a bent toe. Ulcers healed faster or came back less often.[1,2,29] Team care and early referral are linked with fewer major amputations.[3,27]
Don’t wait out a wound. The ADA treats an ulcer that hasn’t shrunk by half after 4 weeks of good care as the point to consider advanced treatment.[31] That is the time for a fresh look at pressure, blood flow, infection and bone, and a surgical opinion. Our Limb Salvage Institute explains surgery that takes pressure off ulcers.
Dr. Efe Ozturk is a Foot and Ankle Surgeon and podiatrist, double board certified, including in wound care. He performs offloading surgery, surgical debridement, skin grafts and flaps, external fixation, and toe and partial foot amputation. Wound VAC therapy and skin substitutes are available when they fit, and when hyperbaric oxygen might help, we refer you. When blood flow is low, we refer you to a vascular specialist. See our wound care, diabetic foot care and Charcot foot pages.
How we built this table
We searched PubMed on November 22, 2026, for systematic reviews, meta-analyses, randomized trials, large cohorts and guidelines on diabetic foot ulcer incidence, healing, recurrence, amputation, mortality and treatment in adults, in English. We added the CDC National Diabetes Statistics Report, Healthy People 2030, the ADA 2026 Standards of Care and the IWGDF 2023 guidelines, plus older landmark trials. We checked every figure against the abstract or official page. Last reviewed November 2026. We update this page as new trials are published.
Limits of these numbers
The studies differ in patients, definitions and follow-up, and the team and referral rows come from observational studies, not randomized trials.[3,27] The podiatry team review judged the evidence insufficient to say podiatry-led teams reduce amputations.[25] The surgical trials were small. Achilles lengthening did not heal ulcers faster in its trial,[2] it likely raises the chance of a heel ulcer, and toe tendon release may cause new sores nearby.[29] After a partial foot amputation, 16% of people died within a year.[17] Nothing here is personal medical advice.
Common questions
What percentage of diabetics have amputations?
In the United States in 2021, there were 6.2 lower-limb amputations for every 1,000 adults with diagnosed diabetes.[7] Once an ulcer forms, the lifetime risk of amputation is about 20%.[5]
Can a diabetic foot ulcer cause death?
An ulcer is linked with a higher death rate: 231 deaths per 1,000 person-years, against 182 without one.[4] One analysis called ulcers and amputations independent risk factors for early death.[8] A spreading infection is an emergency.
What is the diabetic foot ulcer incidence?
In a community study of 6,613 people, 2.2% developed a new ulcer each year,[10] and the lifetime risk is 19% to 34%.[5] Our daily diabetic foot check helps you catch one early.
Can a diabetic foot ulcer heal?
Yes. In one unit, 86.6% of nerve-related ulcers without artery disease or infection healed within a year,[14] and in a trial, surgery healed 95.5%.[1]
Download the data
Every row is in one spreadsheet. Download the table as a CSV file (external site)
How to cite this page
Ozturk E. Diabetic Foot Ulcer and Amputation Statistics (2026): The Numbers in One Table. Ozturk Foot & Ankle. Published November 22, 2026. Updated November 22, 2026. https://www.ozturkfootankle.com/blog/diabetic-foot-ulcer-amputation-statistics (external site)
Reviewed by Dr. Efe Ozturk, Foot and Ankle Surgeon.

About the author
Dr. Efe Ozturk
Foot and Ankle Surgeon. Dr. Ozturk is double board certified, as a Diplomate of the American Board of Podiatric Medicine (DABPM) and a Fellow of the Academy of Physicians in Wound Healing (FAPWH), and is a Fellow of the American Society of Podiatric Surgeons (FASPS) and the American Society of Podiatric Medicine (FASPM). Trained in forefoot and rearfoot reconstructive surgery at Morristown Medical Center; sees patients in Lyndhurst, Paramus and Millburn.
Where to be seen
Dr. Ozturk sees patients at each of these offices, and one phone number reaches all of them.
References
- 1.Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med. 1998;15(5):412-417. PubMed 9609364 (external site)
- 2.Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am. 2003;85(8):1436-1445. PubMed 12925622 (external site)
- 3.Musuuza J, Sutherland BL, Kurter S, Balasubramanian P, Bartels CM, Brennan MB. A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg. 2020;71(4):1433-1446.e3. PubMed 31676181 (external site)
- 4.Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic foot ulcers: a review. JAMA. 2023;330(1):62-75. PubMed 37395769 (external site)
- 5.McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 2023;46(1):209-221. PubMed 36548709 (external site)
- 6.Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care. 2001;24(6):1019-1022. PubMed 11375363 (external site)
- 7.Office of Disease Prevention and Health Promotion. Reduce the rate of foot and leg amputations in adults with diabetes (D-08): data. Healthy People 2030. US Department of Health and Human Services. odphp.health.gov (external site)
- 8.Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):16. PubMed 32209136 (external site)
- 9.Centers for Disease Control and Prevention. National Diabetes Statistics Report. Updated September 16, 2026. cdc.gov (external site)
- 10.Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377-384. PubMed 12027925 (external site)
- 11.Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106-116. PubMed 27585063 (external site)
- 12.Fitridge R, Chuter V, Mills J, et al. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer. Diabetes Metab Res Rev. 2024;40(3):e3686. PubMed 37726988 (external site)
- 13.Xu C, Schmidt BM, Krambrink A, et al. Longitudinal healing and amputation trajectories in diabetic foot ulcers: predictive power of wound area and duration and sample-size implications from the Diabetic Foot Consortium. Wound Repair Regen. 2026;34(4):e70189. PubMed 42458776 (external site)
- 14.Ince P, Game FL, Jeffcoate WJ. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Diabetes Care. 2007;30(3):660-663. PubMed 17327337 (external site)
- 15.Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35(1):78-88. PubMed 29083500 (external site)
- 16.Fu XL, Ding H, Miao WW, Mao CX, Zhan MQ, Chen HL. Global recurrence rates in diabetic foot ulcers: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35(6):e3160. PubMed 30916434 (external site)
- 17.Greenfield SH, Samarth GM, McGregor AH, et al. A systematic review and meta-analysis on partial foot amputation in diabetic foot ulcers. J Vasc Surg. 2026;83(3):879-894.e2. PubMed 41232818 (external site)
- 18.Yammine K, Hayek F, Assi C. A meta-analysis of mortality after minor amputation among patients with diabetes and/or peripheral vascular disease. J Vasc Surg. 2020;72(6):2197-2207. PubMed 32835790 (external site)
- 19.Meshkin DH, Zolper EG, Chang K, et al. Long-term mortality after nontraumatic major lower extremity amputation: a systematic review and meta-analysis. J Foot Ankle Surg. 2021;60(3):567-576. PubMed 33509714 (external site)
- 20.Leatherby RJ, Hicks O, Guéroult A, Azhar B, Holt P, Roy I. Systematic review, meta-analysis, and time to event analysis of contemporary mortality after major lower limb amputation for peripheral arterial disease or diabetes mellitus. Eur J Vasc Endovasc Surg. 2026;71(5):781-792. PubMed 41338377 (external site)
- 21.Hayes J, Rafferty JM, Cheung WY, et al. Impact of diabetes on long-term mortality following major lower limb amputation: a population-based cohort study in Wales. Diabetes Res Clin Pract. 2025;223:112156. PubMed 40216200 (external site)
- 22.Yammine K, Kheir N, Assi C. A meta-analysis of the outcomes of metatarsal head resection for the treatment of neuropathic diabetic foot ulcers. Adv Wound Care (New Rochelle). 2021;10(2):81-90. PubMed 32870773 (external site)
- 23.Bonanno DR, Gillies EJ. Flexor tenotomy improves healing and prevention of diabetes-related toe ulcers: a systematic review. J Foot Ankle Surg. 2017;56(3):600-604. PubMed 28476394 (external site)
- 24.Forsythe RO, Apelqvist J, Boyko EJ, et al. Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes Metab Res Rev. 2020;36 Suppl 1:e3279. PubMed 32176439 (external site)
- 25.Blanchette V, Brousseau-Foley M, Cloutier L. Effect of contact with podiatry in a team approach context on diabetic foot ulcer and lower extremity amputation: systematic review and meta-analysis. J Foot Ankle Res. 2020;13(1):15. PubMed 32192509 (external site)
- 26.Meza-Torres B, Carinci F, Heiss C, Joy M, de Lusignan S. Health service organisation impact on lower extremity amputations in people with type 2 diabetes with foot ulcers: systematic review and meta-analysis. Acta Diabetol. 2021;58(6):735-747. PubMed 33547497 (external site)
- 27.Meloni M, Lazaro-Martínez JL, Ahluwalia R, et al. Effectiveness of fast-track pathway for diabetic foot ulcerations. Acta Diabetol. 2021;58(10):1351-1358. PubMed 33942178 (external site)
- 28.Nickinson ATO, Bridgwood B, Houghton JSM, et al. A systematic review investigating the identification, causes, and outcomes of delays in the management of chronic limb-threatening ischemia and diabetic foot ulceration. J Vasc Surg. 2020;71(2):669-681.e2. PubMed 31676182 (external site)
- 29.Lazzarini PA, Armstrong DG, Crews RT, et al. Effectiveness of offloading interventions for people with diabetes-related foot ulcers: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2024;40(3):e3650. PubMed 37292021 (external site)
- 30.Schaper NC, van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3657. PubMed 37243927 (external site)
- 31.American Diabetes Association Professional Practice Committee for Diabetes. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S261-S276. PubMed 41358886 (external site)
This is general health information and isn’t a substitute for advice from a clinician who knows your history. Read our medical disclaimer and how we write and review content.
More from the blog
Diabetes & wounds
Nerve Decompression for Diabetic Neuropathy: Published Outcomes in One Table (2026)
Every major trial, study, pooled review and guideline on nerve decompression (including the Dellon procedure) for diabetic neuropathy in one table, with the skeptical evidence kept in and every figure checked against its source.
Diabetes & wounds
Poor circulation in the feet: the warning signs of peripheral artery disease
Many people with PAD don’t have the symptoms they expect. The signs to watch for in your feet.
Diabetes & wounds
Diabetes and your feet: the two-minute daily foot check
Diabetes can hide foot injuries from you. A two-minute daily check, and the habits that protect your feet.